One of Europe’s leading strategic management consultants with over 40 years’ experience working with businesses ranging from multinational corporations through to technology-based start-ups and high growth companies. He is currently chair of Scottish Enterprise Pension and Life Assurance Scheme (£800m fund) and Senior Independent Director of Silence Therapeutics PLC a pharmaceutical company listed on the AIM and NASDAQ stock markets. Along with chairing the Edrington Group Staff Share Scheme Trustees Alistair is a published Author.